Method for chemical-biological combined synthesis of L-glufosinate-ammonium and mutant

2-carbonyl-4-(hydroxymethylphosphono)butyric acid was synthesized from diethyl methyl phosphite through a chemical-biological grade combined process, and wet bacteria co-expressed by glufosinate dehydrogenase and alcohol dehydrogenase using glufosinate dehydrogenase and alcohol dehydrogenase. The body or mutant is biocatalyzed, solving the problems of L-glufosinate synthesis and the use of highly toxic cyanides, and achieving efficient, stable and low-waste L-glufosinate production.

CN118931985APending Publication Date: 2024-11-12ZHEJIANG UNIV OF TECH
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410819732.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-07-07
Filing Date
2024-06-24
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing L-glufosinate synthesis process has problems such as complex locking, low asymmetric amination reduction activity and poor stability. The use of highly toxic cyanide and D,L-glufosinate synthesis in the traditional route leads to the generation of three wastes. High quantity.

Method used

Using chemical-biological grade combined process, starting from diethyl methyl phosphite, 2-carbonyl-4-(hydroxymethylphosphono)butyric acid was synthesized through addition, condensation and hydrolysis reactions, and dehydrogenation was used by glufosinate ammonium Wet bacteria or mutants co-expressed by enzymes and alcohol dehydrogenase are used as biocatalysts to synthesize L-glufosinate ammonium to avoid the use of highly toxic cyanide.

Benefits of technology

It has achieved efficient and stable synthesis of L-glufosinate, with a conversion rate of 100%, high optical purity of the product, and a reduction of the three waste production by more than 50%. It has a simple process and is easy to industrially and continuously produced.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

The method comprises the following steps: carrying out an addition reaction on diethyl methylphosphite and acrylic acid to synthesize ethyl 3-(methyl ethoxy phosphonyl) propionate, carrying out a condensation reaction on the ethyl 3-(methyl ethoxy phosphonyl) propionate and sodium ethoxide, carrying out a chemical-biological combined reaction on the ethyl 3-(methyl ethoxy phosphonyl) propionate and sodium ethoxide to obtain the L-glufosinate-ammonium mutant. The method comprises the following steps: synthesizing 2-carbonyl-4-(hydroxymethylphosphonyl) butyric acid by using a glufosinate-ammonium dehydrogenase mutant as a raw material, hydrolyzing with diethyl oxalate to synthesize 2-carbonyl-4-(hydroxymethylphosphonyl) butyric acid, and finally synthesizing L-glufosinate-ammonium by using a glufosinate-ammonium dehydrogenase and alcohol dehydrogenase co-expression wet cell or a glufosinate-ammonium dehydrogenase mutant and alcohol dehydrogenase co-expression wet cell as a biocatalyst. The asymmetric amination reduction activity is not high; and the stability is poor. The process route is green, simple and mild, highly toxic cyanide used for synthesizing D, L-glufosinate-ammonium is avoided, and compared with D, L-glufosinate-ammonium, the yield of three wastes is reduced by more than 50%. The conversion rate of the biological catalysis step reaches 100%, no substrate is left, and the ee value of the product is greater than 99%.
Need to check novelty before this filing date? Find Prior Art

Description

(I) Technical field

[0001] The invention belongs to the technical field of bioengineering and chemical engineering, and specifically relates to a new process for synthesizing L-glufosinate ammonium by biocatalyst, mutant and chemical-biological cascade. (II) Background technology

[0002] Glufosinate, also known as glufosinate, is called Phsophinothricin (PPT for short) in English. Its chemical name is 2-amino-4-[hydroxy(methyl)phosphonyl]-butyric acid. It has the characteristics of high herbicidal activity, broad herbicidal spectrum and good environmental compatibility, and is very suitable for the development of herbicide resistance genes. Glufosinate resistance genes have been introduced into more than 20 crops such as rice, wheat, corn, sugar beet, tobacco, soybean, cotton, potato, tomato, rapeseed, sugarcane, etc. In recent years, these transgenic crops have been promoted in agricultural countries in America, Asia, Europe, Australia and other regions, and their application prospects are very broad. However, at present, the glufosinate sold on the market is generally a racemic mixture. Among them, 50% D-glufosinate has no herbicidal activity, and only the L-configuration has phytotoxicity, and is easily decomposed in the soil, with low toxicity to humans and animals and low destructive power to the environment. If glufosinate products can be used in the form of L-configuration optically pure isomers, the amount of glufosinate used can be reduced by 50%, which is of great significance for improving atom economy, reducing costs and alleviating environmental pressure.

[0003] The methods for producing L-glufosinate include chemical synthesis, fermentation, and biosynthesis. Among them, the enzymes involved in the biosynthesis method mainly include: protease, deacetylase, transaminase, amidase, ester hydrolase, and nitrile hydratase. In many enzymatic synthesis routes of glufosinate, the keto carbonyl group of the keto acid intermediate is a potential chiral functional group, which can be used to construct a chiral center through enzymatic synthesis. The keto acid route has also become a suitable route for the industrial development and production of L-glufosinate because the raw materials are cheap and easy to obtain and can avoid the use of highly toxic cyanide.

[0004] The biocatalytic method for producing glufosinate has the advantages of strict stereoselectivity, mild reaction conditions, and high yield, and is an advantageous method for producing L-glufosinate. It mainly includes the following three categories:

[0005] 1) Using L-phosphinothricin derivatives as substrates, it is obtained by direct enzymatic hydrolysis. The main advantages are high conversion rate and high product ee value, but expensive and difficult to obtain chiral raw materials are required as precursors, which increases the cost and is not conducive to industrial production. For example, the simplest method for preparing L-phosphinothricin by biological method is to use protease to directly hydrolyze bialaphos. Bialaphos is a natural tripeptide compound. Under the catalysis of protease, bialaphos removes 2 molecules of L-alanine to generate L-phosphinothricin.

[0006] 2) Using the precursor of racemic glufosinate as a substrate, it is obtained by selective enzyme splitting. The main advantages are that the raw materials are relatively easy to obtain and the catalyst activity is high, but its theoretical yield can only reach 50%, which will cause waste of raw materials. For example, Cao et al. (Cao C-H, Cheng F, Xue YP, Zheng YG (2020) Efficient synthesizes Pseis of L-phosphinothricin using a novel aminoacylase mined from Stenotrophomonas maltophilia. Enzyme and Microbial Technology 135 doi: 10.1016 / j.enzmictec.2019.109493) used a new aminoacylase derived from Stenotrophomonas maltophilia to chirally split N-acetyl-PPT to obtain L-glufosinate. Using whole cells for catalysis, the conversion rate was >49% within 4 hours, and optically pure L-PPT (>99.9% ee) was obtained.

[0007] 3) Using 2-carbonyl-4-(hydroxymethylphosphonyl)butyric acid (PPO) as substrate, it was obtained by enzymatic asymmetric synthesis, and the enzymes involved mainly included transaminase and glufosinate dehydrogenase. Bartsch (Bartsch K (2005) Proc PsPse for the preparation of L-phosphinothrcine by enzymatic transamination with aspartate. US Patent no. US6936444B1) et al. used PPO as substrate, L-aspartic acid as amino donor, and used transaminase with specific enzyme activity for PPO and L-aspartic acid screened and separated from soil microorganisms for catalysis. When the substrate concentration was 552 mM, the reaction was carried out at a very high temperature (80°C) for 4 hours, and the conversion rate still reached 52%, and the space-time yield was 4.5 g L-PPT / g·L -1 ·d -1 However, there are two major drawbacks in using transaminase to prepare L-phosphinothricin. First, this is a reversible reaction, and the raw material PPO cannot be completely converted into L-PPT, and the conversion rate cannot reach 100%. Second, in order to make the reversible reaction proceed in the direction of generating L-PPT, at least 2 times more L-aspartic acid needs to be added as an amino donor. Excessive aspartic acid brings great trouble to the separation of L-PPT.

[0008] Glufosinate ammonium dehydrogenase has two types: NADH-dependent and NADPH-dependent. Both types can use inorganic ammonia donors for asymmetric amination reactions to synthesize L-glufosinate ammonium with PPO as the substrate. The difference is that different types of glufosinate ammonium dehydrogenase require different coenzymes: NADH-dependent glufosinate ammonium dehydrogenase requires the coenzyme NADH (CN114350631A) for catalytic reactions, while NADPH-type glufosinate ammonium dehydrogenase requires NADPH (CN109609475A). The conversion rate can reach 100%. However, the chemical synthesis of the substrate PPO is also the key to the preparation of L-glufosinate ammonium. A clean and safe synthesis process is the key to success. The traditional D,L-glufosinate synthesis process involves highly toxic cyanide. Finding a similar synthesis process for PPO from the traditional route does not conform to the concept of environmental protection.

[0009] To this end, the present invention starts from diethyl methylphosphite, synthesizes PPO through addition, condensation and hydrolysis reactions, eliminates the use of highly toxic cyanide, and reduces the amount of three wastes produced by more than 50% compared with DL-glufosinate. Further, L-glufosinate is asymmetrically synthesized through biological inorganic amination reaction. The entire chemical-enzymatic synthesis process is simple, the reaction conditions are mild, and industrial amplification is easy to achieve continuous production. (III) Summary of the invention

[0010] The invention aims to provide a method and mutant for chemical-biological cascade synthesis of L-phosphinothricin. The method comprises the following steps: synthesizing ethyl 3-(methylethoxyphosphinothricin)propionate by addition reaction of diethyl methylphosphite and acrylic acid, then subjecting ethyl 3-(methylethoxyphosphinothricin)propionate to condensation reaction with sodium ethoxide, and then hydrolyzing the ethyl 3-(methylethoxyphosphinothricin)propionate with diethyl oxalate to synthesize 2-carbonyl-4-(hydroxymethylphosphinothricin)butyric acid, and finally using wet bacterial cells co-expressing glufosinate dehydrogenase with high activity and good stability or wet bacterial cells co-expressing glufosinate dehydrogenase mutant and alcohol dehydrogenase as biocatalysts to catalyze synthesis of L-phosphinothricin by using 2-carbonyl-4-(hydroxymethylphosphinothricin)butyric acid as raw material, thereby solving the problems of complicated synthesis of L-phosphinothricin, low asymmetric amination reduction activity and poor stability.

[0011] The technical solution adopted by the present invention is:

[0012] The present invention provides a method for synthesizing L-glufosinate-ammonium, the method comprising the following steps:

[0013] The wet cells obtained by fermentation culture of recombinant Escherichia coli engineering bacteria co-expressing the coding genes of glufosinate ammonium dehydrogenase and alcohol dehydrogenase or the wet cells obtained by fermentation culture of recombinant Escherichia coli engineering bacteria co-expressing the coding genes of glufosinate ammonium dehydrogenase mutant and alcohol dehydrogenase were used as catalysts, 2-carbonyl-4-(hydroxymethylphosphonyl)butyric acid was used as substrate, isopropanol, NAD +, a reaction system is formed with a buffer solution of pH 6-8 as a reaction medium, a conversion reaction is carried out at 40-60° C. and 100-200 rpm, and the reaction solution is separated and purified to obtain L-phosphinothricin ammonium; the glufosinate ammonium dehydrogenase mutant is obtained by performing a single mutation or a double mutation at the 73rd or 91st position of the glufosinate ammonium dehydrogenase with an amino acid sequence as shown in SEQ ID NO.2.

[0014] Preferably, the 2-carbonyl-4-(hydroxymethylphosphonyl)butyric acid is prepared according to the following steps:

[0015] (1) using diethyl methylphosphite and acrylic acid (preferably with a purity of 98%) as raw materials, and synthesizing ethyl 3-(methylethoxyphosphonyl)propionate by addition reaction at a temperature of 100-150° C. and a pressure of 0.5-5 MPa;

[0016] (2) After condensation reaction of ethyl 3-(methylethoxyphosphonyl)propionate with sodium ethoxide and diethyl oxalate at a temperature of 40-80° C. and a pressure of 1-5 MPa, the pH is adjusted to 6-8 (preferably 7.5), and hydrolysis reaction is carried out by heating at 50-70° C. The reaction solution is subjected to a small distillation tower to recover the by-product ethanol, and then sodium chloride is removed by filtration to obtain 2-carbonyl-4-(hydroxymethylphosphonyl)butyric acid.

[0017]

[0018] Preferably, the temperature of step (1) is 120° C., the pressure is 1 MPa, and the reaction time is 6 hours. The volume ratio of acrylic acid to diethyl methyl phosphite is 1-5:1, preferably 1.1:1.

[0019] Preferably, the condensation reaction conditions in step (2) are: reaction at a temperature of 60° C. and a pressure of 1.5 MPa for 8 hours; the hydrolysis reaction temperature is 60° C. The volume amount of ethyl 3-(methylethoxyphosphonyl)propionate is 20-50 L / kg, preferably 36.5 L / kg, based on the mass of sodium ethoxide; the mass ratio of sodium ethoxide to diethyl oxalate is 1:1-3, preferably 1:1.

[0020] Preferably, in the reaction system, the wet bacteria are added to a final concentration of 10-40 g / L (preferably 10 g / L), the substrate is added to a final concentration of 200-800 mM, preferably 200 mM; isopropanol is added to a final concentration of 200-1000 mM, preferably 300 mM; NAD + The final concentration of the added solution is 0.4-0.8 mM, preferably 0.6 mM; the reaction medium is preferably a phosphate buffer solution with a pH of 7.5.

[0021] Preferably, the glufosinate dehydrogenase mutant is a mutant in which the amino acid sequence shown in SEQ ID NO.2 is mutated to one of the following: (1) the valine at position 73 is mutated to cysteine, V73C; (2) the methionine at position 91 is mutated to glycine, M91G; (3) the valine at position 73 is mutated to cysteine ​​and the methionine at position 91 is mutated to glycine, V73C-M91G.

[0022] The amino acid sequence of the glufosinate dehydrogenase of the present invention is shown in SEQ ID NO.2, and the nucleotide sequence of the encoding gene is shown in 1; the amino acid sequence of the alcohol dehydrogenase is shown in SEQ ID NO.4, and the nucleotide sequence of the encoding gene is shown in SEQ ID NO.3.

[0023] Preferably, the catalyst preparation method is: inoculate the recombinant Escherichia coli engineering bacteria containing the co-expression gene encoding the glufosinate dehydrogenase and the alcohol dehydrogenase or the co-expression gene encoding the glufosinate dehydrogenase mutant and the alcohol dehydrogenase into the LB liquid culture medium containing the final concentration of 50 μg / mL ampicillin, culture at 37°C for 8 hours, inoculate into the fresh LB liquid culture medium containing the final concentration of 50 μg / mL ampicillin at an inoculum concentration of 2% by volume, culture at 37°C and 180 rpm for 2 hours, then add IPTG with a final concentration of 0.1 mM to the culture solution, culture at 18°C ​​for 14 hours, centrifuge at 4°C and 8000 rpm for 10 minutes to obtain the corresponding wet bacterial cells. The wet bacterial cells produce the corresponding protein, which can be used for the preparation of protein pure enzyme solution, and can also be used for the preparation of immobilized cells.

[0024] Preferably, the co-expression recombinant E. coli engineering bacteria containing the glufosinate dehydrogenase encoding gene and the alcohol dehydrogenase encoding gene is constructed as follows: the alcohol dehydrogenase gene ADH (nucleotide sequence as shown in SEQ ID No. 3) is constructed into the NdeI and AvrⅡ of the MCS2 (multiple cloning site 2) of the recombinant expression vector pETDuet-LcGluDH by the One Step Cloning Kit of Vazyme Company to obtain the co-expression vector pETDuet-LcGluDH-ADH, which is transformed into E. coli BL21 (DE3) to obtain the glufosinate dehydrogenase and alcohol dehydrogenase co-expression strain E. coli BL21 (DE3) / pETDuet-LcGluDH-ADH. In the same way, the co-expression recombinant E. coli engineering bacteria containing the encoding gene of the glufosinate dehydrogenase mutant and the alcohol dehydrogenase encoding gene are constructed.

[0025] The present invention also provides a glufosinate dehydrogenase mutant for synthesizing L-glufosinate. The glufosinate dehydrogenase mutant is obtained by subjecting the amino acid sequence of the glufosinate dehydrogenase shown in SEQ ID NO.2 to a single mutation or a double mutation at position 73 or 91, and preferably the amino acid sequence shown in SEQ ID NO.2 is mutated to one of the following: (1) the valine at position 73 is mutated to cysteine, V73C; (2) the methionine at position 91 is mutated to glycine, M91G; (3) the valine at position 73 is mutated to cysteine ​​and the methionine at position 91 is mutated to glycine, V73C-M91G.

[0026] Compared with the prior art, the beneficial effects of the present invention are mainly reflected in:

[0027] 1) The traditional route starts from the existing D,L-phosphinothricin to obtain L-phosphinothricin by splitting, while the route of the present invention innovatively adopts chemical-biological cascade synthesis technology to produce L-phosphinothricin with conventional compounds instead of D,L-phosphinothricin as raw materials, abandoning the technical route of synthesizing D,L-phosphinothricin by Strecker reaction and then splitting to obtain L-phosphinothricin.

[0028] 2) The process route of the present invention is green, because the process does not need to synthesize D,L-glufosinate, so the highly toxic cyanide used in the synthesis of D,L-glufosinate is avoided, and the amount of three wastes generated is reduced by more than 50% compared with D,L-glufosinate.

[0029] 3) The process of the present invention is simple, the conditions of the chemical reaction step and the biological reaction step are mild, and industrial scale-up is easy to achieve continuous production.

[0030] 4) By coupling the glufosinate ammonium dehydrogenase mutant of the present invention and alcohol dehydrogenase, the conversion rate of the biocatalytic step reaches 100%, no substrate remains, and the product ee value is greater than 99%. Compared with the existing method, separation and purification are convenient. (IV) Description of the drawings

[0031] Figure 1 Schematic diagram of the reaction equation for the biosynthesis of L-phosphinothricin.

[0032] Figure 2 This is the physical map of the pETDuet-LcGluDH-ADH recombinant plasmid in Example 3.

[0033] Figure 3 It is the SDS-PAGE diagram in Example 3; wherein, lane 1 is the protein molecular weight marker, and lane 2 is the supernatant of ultrasonic disruption of wet bacteria co-expressing glufosinate dehydrogenase LcGluDH and alcohol dehydrogenase ADH.

[0034] Figure 4This is a high performance liquid chromatography (HPLC) spectrum analysis chart of 2-carbonyl-4-(hydroxymethylphosphonyl)butyric acid standard.

[0035] Figure 5 High performance liquid chromatography (HPLC) spectral analysis diagram of D-PPT standard and L-PPT standard.

[0036] Figure 6 This is a diagram showing the reaction process of 200 mM 2-carbonyl-4-(hydroxymethylphosphono)butyric acid catalyzed by recombinant E. coli BL21(DE3) / pETDuet-LcGluDH-ADH and mutants.

[0037] Figure 7 This is a diagram showing the reaction process of 800 mM 2-carbonyl-4-(hydroxymethylphosphono)butyric acid catalyzed by recombinant E. coli BL21(DE3) / pETDuet-LcGluDH-ADH and mutants. (V) Specific implementation methods

[0038] The present invention is further described below in conjunction with specific embodiments, but the protection scope of the present invention is not limited thereto:

[0039] Example 1, large-scale chemical synthesis of ethyl 3-(methylethoxyphosphonyl)propionate

[0040] At 5m 3 2000L of diethyl methylphosphite (content 98%) was added to a high-pressure reactor, and 2200L of acrylic acid was added under stirring at 100rpm for addition reaction. The reaction temperature was controlled at 120°C and the pressure was 1MPa. After 6 hours of reaction, the reaction solution was filtered after recovering the by-product ethanol through a small distillation tower to obtain 2500L of ethyl 3-(methylethoxyphosphonyl)propionate. The yield of the addition reaction was determined to be 96% by HPLC.

[0041] Example 2: Synthesis of 2-carbonyl-4-(hydroxymethylphosphonyl)butyric acid from ethyl 3-(methylethoxyphosphonyl)propionate

[0042] At 5m 3Add 3000L of ethyl 3-(methylethoxyphosphonyl)propionate prepared by the method of Example 1 and 82kg of sodium ethoxide into the condensation reactor, add 86kg of diethyl oxalate, react for 8 hours at a reaction temperature of 60°C and a pressure of 1.5MPa; then add a certain amount of hydrochloric acid (measured by the reaction pH) to adjust the pH to 7.5; then heat the reaction, control the reaction temperature at 60°C, and distill off the by-product ethanol to distill and recover 95% ethanol. After the reaction, filter and remove sodium chloride to obtain a 2-carbonyl-4-(hydroxymethylphosphonyl)butyric acid solution with a concentration of 10mol / L, a volume of 3.2L, and a measured pH of 1.5.

[0043] Example 3: Construction and expression of glufosinate dehydrogenase parent engineered bacteria and starting co-expression strains

[0044] 1. Glufosinate dehydrogenase parent engineering bacteria E.coli BL21(DE3) / pETDuet-LcGluDH

[0045] The amino acid sequence of the LcGluDH gene (NCBI accession number 8I83) derived from Lysinibacillus composti was codon optimized (the nucleotide sequence after codon optimization is shown in SEQ ID No. 1, and the amino acid sequence is shown in SEQ ID No. 2), and gene synthesis was performed by Hangzhou Qingke Biotechnology Co., Ltd. to obtain the LcGluDH gene, which was cloned into NcoI of MCS1 (multiple cloning site 1) of the plasmid pETDuet to construct a recombinant expression vector pETDuet-LcGluDH, retaining the His-Tag gene of the plasmid itself, and transformed into Escherichia coli E. coli BL21 (DE3), and sent to Hangzhou Qingke Biotechnology Co., Ltd. to synthesize the mother engineering bacteria E. coli BL21 (DE3) / pETDuet-LcGluDH of glufosinate dehydrogenase.

[0046] The glufosinate dehydrogenase mother engineering bacteria E.coli BL21 (DE3) / pETDuet-LcGluDH was inoculated into an LB liquid culture medium containing a final concentration of 50 μg / mL ampicillin, and cultured at 37 ° C for 8 hours. The inoculum volume concentration was 2% and inoculated into a fresh LB liquid culture medium containing a final concentration of 50 μg / mL ampicillin, and cultured at 37 ° C and 180 rpm for 2 hours. IPTG with a final concentration of 0.1 mM was added to the culture solution. After culturing at 18 ° C for 14 hours, the culture was centrifuged at 4 ° C and 8000 rpm for 10 minutes to obtain the wet cells of the glufosinate dehydrogenase mother engineering bacteria.

[0047] 2. Starting co-expression strain E.coli BL21(DE3) / pETDuet-LcGluDH-ADH

[0048] Then, the alcohol dehydrogenase gene ADH (PDB accession number 1rjw, nucleotide sequence as shown in SEQ ID No. 3, amino acid sequence as shown in SEQ ID No. 4) was cloned from Bacillus stearothermophilus and constructed into the NdeI and AvrⅡ of MCS2 (multiple cloning site 2) of the recombinant expression vector pETDuet-LcGluDH using the One Step Cloning Kit of Vazyme Company to obtain the co-expression vector pETDuet-LcGluDH-ADH (see the plasmid map) Figure 2 ), transformed into E. coli BL21 (DE3), and obtained the starting co-expression strain E. coli BL21 (DE3) / pETDuet-LcGluDH-ADH of glufosinate dehydrogenase parent and alcohol dehydrogenase.

[0049] The starting co-expression strain E.coli BL21 (DE3) / pETDuet-LcGluDH-ADH was inoculated into LB liquid culture medium containing a final concentration of 50 μg / mL ampicillin, and cultured at 37 ° C for 8 hours. It was inoculated into a fresh LB liquid culture medium containing a final concentration of 50 μg / mL ampicillin at an inoculum concentration of 2% by volume, and cultured at 37 ° C and 180 rpm for 2 hours. IPTG with a final concentration of 0.1 mM was added to the culture solution. After culturing at 18 ° C for 14 hours, it was centrifuged at 4 ° C and 8000 rpm for 10 minutes to obtain the wet bacteria of the starting co-expression strain.

[0050] 0.2 g of wet cells were suspended in 10 ml of binding buffer (pH 7.4, 100 mM sodium phosphate buffer containing 0.3 M NaCl), ultrasonically disrupted for 15 min (ice bath, power 400 W, disruption for 1 s, pause for 5 s), centrifuged at 4°C, 12,000 rpm for 20 min, and the supernatant was subjected to agarose gel electrophoresis. SDS-PAGE is shown in Figure 2. Figure 3 shown.

[0051] Example 4: Construction and screening of a co-expression library of glufosinate dehydrogenase mutants

[0052] 1. Glufosinate dehydrogenase mutant co-expression library

[0053] The preparation of the co-expression library of glufosinate ammonium dehydrogenase mutants was achieved by random point saturation mutagenesis. The primers were designed as shown in Table 1. The vector pETDuet-LcGluDH-ADH was used as a template to perform site-directed saturation mutagenesis PCR. The PCR results were verified by DNA agarose gel electrophoresis. The PCR products were digested with DpnI enzyme templates, inactivated at 37°C for 1 hour, 220 rpm, and 65°C for 1 minute. The PCR products were heat-shocked and transformed, and Escherichia coli E. coli BL21 (DE3) was activated and cultured at 37°C and 220 rpm for 1 hour. The plates were spread on LB plates containing 50 μg / mL ampicillin resistance and cultured inverted at 37°C overnight. The grown strains were picked to be the co-expression library of glufosinate ammonium dehydrogenase mutants.

[0054] The mutation PCR system (100 μL) was: 25 μL of 2x DNAtaq polymerase buffer, 1 μL of dNTPs, 1 μL of each mutation upper and lower primers, 1 μL of template, 0.5 μL of DNAtaq polymerase, 1 μL of 10 mM MnCl2 solution, and ddH2O to 50 μL.

[0055] The PCR conditions were as follows: pre-denaturation at 95°C for 5 minutes, 30 cycles of 90°C for 30 seconds, 60°C for 30 seconds, 72°C for 2 minutes, and final extension at 72°C for 5 minutes.

[0056] Table 1 Primer design for site-directed saturation mutagenesis of glufosinate dehydrogenase

[0057]

[0058]

[0059] Note: In Table 1, N stands for A / C / G / T, M stands for A / C, and K stands for G / T.

[0060] 2. Induced expression of glufosinate dehydrogenase mutant co-expression engineering bacteria

[0061] The strains from step 1 were inoculated into LB liquid culture medium containing a final concentration of 50 μg / mL ampicillin, and cultured at 37°C for 8 hours. The inoculation amount was inoculated into fresh LB liquid culture medium containing a final concentration of 50 μg / mL ampicillin at a volume concentration of 2%, and cultured at 37°C and 180 rpm for 2 hours. IPTG with a final concentration of 0.1 mM was then added to the culture solution. After culturing at 18°C ​​for 14 hours, the culture was centrifuged at 4°C and 8000 rpm for 10 minutes to obtain the corresponding wet bacteria.

[0062] The cells obtained above produce corresponding proteins, which can be used to prepare pure protein enzyme solution and can also be used to prepare immobilized cells.

[0063] 3. Screening of mutant co-expression library

[0064] The glufosinate ammonium dehydrogenase prepared by the method of Example 3 and the alcohol dehydrogenase co-expression wet bacteria or the glufosinate ammonium dehydrogenase mutant prepared by the method of step 2 and the alcohol dehydrogenase co-expression wet bacteria were used as catalysts, the intermediate product 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid was used as a substrate, isopropanol was used as a cosubstrate, and a trace amount of NAD was added exogenously. + , pH 7.5, 100mM phosphate buffer was used as the reaction medium to form a 1mL reaction system, the catalyst dosage was 10g / L based on the final concentration of wet bacteria, the final concentration of substrate was 100mM, the final concentration of isopropanol was 120mM, and NAD + The final concentration was 0.4mM. The reaction was carried out at 55°C and 600 rpm for 5 min. 50 μL of the reaction solution was taken and 5 μL of hydrochloric acid was added to terminate the reaction. The reaction solution was diluted 100 times with ultrapure water. 200 μL of the diluted reaction solution was taken + 400 μL of the derivatization reagent (containing 15 mM o-phthalaldehyde, 15 mM N-acetyl-L-cysteine, pH 9.8 boric acid buffer) was derivatized at 30°C for 5 min. 400 μL of ultrapure water was added to make up to 1 mL. The solution was centrifuged at 12000 rpm for 1 min. The supernatant was taken and passed through a 0.22 μM microfiltration membrane. The filtrate was collected as a liquid sample. The liquid phase detection was used to measure 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid, L-phosphinothricin, D-phosphinothricin and ee values. The superior mutants were screened with the product L-phosphinothricin and ee as indicators. The experimental results are shown in Tables 2 and 3.

[0065] 2-Carbonyl-4-(hydroxymethylphosphonyl)-butyric acid Liquid phase detection conditions: Chromatographic column Unitary○ R C18 (4.6×250 mm, Acchrom, China), mobile phase acetonitrile: 50 mM ammonium dihydrogen phosphate solution (pH 3.8, containing 10% tetrabutylammonium hydroxide) volume ratio of 12:88. Flow rate 1 mL / min, detection wavelength 232 nm, injection volume 10 μL, column temperature 40°C, 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid retention time: 11.1 minutes.

[0066] Glufosinate liquid phase detection conditions: chromatographic column Unitary○ R C18 (4.6×250 mm, Acchrom, China), mobile phase methanol: 0.05 M ammonium acetate (pH 5.7) volume ratio of 10:90, flow rate 1.0 mL / min, detection wavelength Ex=340 nm, Em=450 nm, injection volume 10 μL, column temperature 35° C. The retention times of L-phosphinothricin and D-phosphinothricin were 13 minutes and 15.5 minutes, respectively.

[0067] Table 2 Conversion rate of multienzyme catalytic reaction after site-directed saturation mutation of LcGluDH (5 min reaction)

[0068] Mutation at position 73 Conversion rate (%) Mutation at position 91 Conversion rate (%) WT 12 WT 12 V73A ND M91A ND V73N ND ND ND V73D ND M91D ND V73C 45 M91C 12 V73Q ND M91Q 3.4 V73E 3.2 M91E ND V73G 10.1 M91G 60 V73H ND M91H 10.8 V73I 10.4 M91I ND V73L ND M91L ND V73K ND M91K 2.2 V73M 12 M91M 2.6 V73F ND M91F ND V73P 4.5 M91P ND V73S ND M91S ND V73T ND M91T ND V73W ND M91W ND V73Y ND M91Y 2.1 V73R ND M91V ND

[0069] ND: Not Detectable

[0070] Table 3 Catalytic performance and stereoselectivity of LcGluDH and its mutants (co-expression strains)

[0071] Mutation site L-Glufosinate(mM) Conversion rate (%) ee(%) LcGluDH-ADH 1.482 12 99.9 LcGluDH-V73C-ADH 20.265 45 99.9 LcGluDH-M91G-ADH 26.525 60 99.9 LcGluDH-V73C-M91G-ADH 45.432 80.1 99.9

[0072] Note: The conversion rate is based on the data of 100 mM substrate reaction for 5 minutes.

[0073] Table 2 shows that the strain V73C with improved activity was screened out through site saturation mutagenesis and screening of V73; and the strain M91G with improved activity was screened out through site saturation mutagenesis and screening of M91.

[0074] It can be seen from Table 3 that when exogenous NAD is added + Under the same conditions, the glufosinate dehydrogenase mutant V73C can increase the conversion rate of 100mM PPO from 12% to 45%. + Under the conditions, the mutant of glufosinate dehydrogenase M91G increased the conversion rate of 300mM substrate from 12% to 60%. Then the two mutation points V73C and M91G were combined and mutated, and it was found that the activity was further improved, and the conversion rate of 100mM substrate reached 80.1%.

[0075] Example 5: Purification of phosphinothricin dehydrogenase parent and its mutants

[0076] The wet cells of the glufosinate dehydrogenase mother engineering bacteria E. coli BL21 (DE3) / pETDuet-LcGluDH prepared in Example 3 and the catalytic performance results of the glufosinate dehydrogenase mutant co-expressing engineering bacteria screened in Example 4 were used to construct engineering bacteria expressing glufosinate dehydrogenase alone (E. coli BL21 (DE3) / pETDuet-LcGluDH-V73C, E. coli BL21 (DE3) / pETDuet-LcGluDH-M91G, E. coli BL21 (DE3) / pETDuet-LcGluDH-V73C-M91G). The wet cells of the glufosinate dehydrogenase mutants were prepared according to the method of the wet cells of the mother engineering bacteria in Example 3.

[0077] Take 0.2 g of wet cells of the glufosinate dehydrogenase parent engineering bacteria and the glufosinate dehydrogenase mutant engineering bacteria, respectively, suspend them in 10 ml of binding buffer (pH 7.4, 100 mM sodium phosphate buffer containing 0.3 M NaCl), ultrasonically disrupt them for 15 minutes (ice bath, power 400 W, disruption for 1 second, pause for 5 seconds), centrifuge at 4°C and 12000 rpm for 20 min, and take the supernatant as a sample.

[0078] The protein was purified using a Ni affinity column (1.6×10 cm, Bio-Rad, USA) with the following specific steps: ① Equilibrate the Ni column with 5 column volumes of binding buffer (pH 7.4, 50 mM sodium phosphate buffer containing 0.3 M NaCl) until the baseline is stable; ② Load the sample at a flow rate of 1 mL / min, with a sample volume of 200 mg based on protein content, so that the target protein is adsorbed on the Ni column; ③ Wash the impurities with 6 column volumes of buffer A (pH 7.4, 50 mM sodium phosphate buffer containing 0.3 M NaCl and 30 mM imidazole) at a flow rate of 1 mL / min until the baseline is stable; ④ Elute with buffer B (pH 7.4, 50 mM sodium phosphate buffer containing 0.3 M NaCl and 500 mM imidazole) at a flow rate of 1 mL / min for 6 column volumes to collect the target protein. The target protein was dialyzed in pH 7.4, 20mM phosphate buffer (dialysis bag molecular weight cutoff 10kDa) overnight, and the retentate was collected to obtain 10ml of pure enzyme solution of glufosinate ammonium dehydrogenase parent and 10ml of pure enzyme solution of glufosinate ammonium dehydrogenase mutant, respectively; ⑤ Rinse the Ni column with 5 column volumes of binding buffer (pH 8.0, 50mM sodium phosphate buffer containing 0.3M NaCl) until the baseline is stable, and preserve the Ni column with 5 column volumes of ultrapure water containing 20% ​​ethanol.

[0079] The protein concentration of the pure enzyme solution was determined using a BCA protein assay kit (Nanjing KeyGen Biotechnology Development Co., Ltd., Nanjing). The results are shown in Table 4.

[0080] Table 4 Protein concentration of pure enzyme solution of glufosinate dehydrogenase parent and its mutants

[0081] Enzymes Protein concentration LcGluDH 0.24 (μg / μL) LcGluDH-V73C 0.5 (μg / μL) LcGluDH-M91G 0.4 (μg / μL) LcGluDH-V73C-M91G 0.22 (μg / μL)

[0082] Example 6: Determination of the specific enzyme activity of the parent glufosinate dehydrogenase and its mutants

[0083] The enzyme activity unit (U) is defined as: the amount of enzyme required to generate 1 μmol of L-phosphinothion per minute at 55°C and pH 7.5. The specific enzyme activity is defined as the number of activity units per milligram of enzyme protein, U / mg.

[0084] Standard conditions for enzyme activity detection: Take the pure enzyme of the parent glufosinate dehydrogenase and its mutants with a protein content of 0.22 mg prepared by the method of Example 5, add 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid at a final concentration of 100 mM and coenzyme NADH at a final concentration of 10 mM to form a reaction system with a total volume of 10 mL; react at 55° C., pH 7.5, 600 rpm for 10 minutes, and perform HPLC detection and analysis using the method of Example 4. The results are shown in Table 5.

[0085] Table 5 Specific enzyme activity of glufosinate dehydrogenase parent and its mutants

[0086] Enzymes Relative enzyme activity (%) ee(%) LcGluDH <![CDATA[100 a ]]> 99.9 LcGluDH-V73C 25298±12.5 99.9 LcGluDH-M91G 3125.8±10..8 99.9 LcGluDH-V73C-M91G 3986.2±17.5 99.9

[0087] a : The initial enzyme activity of each glufosinate dehydrogenase parent under standard conditions was assigned as 100%.

[0088] Example 7: Conversion of 200 mM 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid by E. coli BL21(DE3) / pETDuet-LcGluDH-ADH

[0089] In a 3L conventional stirred reactor, 200mL of 2M 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid solution prepared by the method of Example 2 was added, the pH was adjusted to 7.5 with aqueous ammonia, and a final concentration of 240mM isopropanol and 0.4mM NAD + , 10 g / L of E. coli BL21 (DE3) / pETDuet-LcGluDH-ADH prepared by the method of Example 3, the reaction system was supplemented to 2000 mL with phosphate buffer at pH = 7.5, and the reaction was carried out at a temperature of 55 ° C and 150 rpm for 15 hours. The reaction solution was detected by liquid phase detection using the method of Example 4 ( Figure 6 ), the residual concentration of the substrate was 150 mM, the conversion rate was 25%, the L-PPT was 48 mM, and the ee value of the product L-phosphinothricin was 99.9%.

[0090] The liquid chromatogram of 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid standard is shown in Figure 4 The liquid chromatograms of D-PPT and L-PPT standards are shown in Figure 5 shown.

[0091] Example 8: Conversion of 200 mM 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid by E. coli BL21(DE3) / pETDuet-LcGluDH-V73C-ADH

[0092] In a 3L conventional stirred reactor, 200mL of 2M 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid solution prepared by the method of Example 2 was added, the pH was adjusted to 7.5 with aqueous ammonia, and a final concentration of 240mM isopropanol and 0.4mM NAD + , 10 g / L of E. coli BL21 (DE3) / pETDuet-LcGluDH-ADH prepared by the method of Example 3, the reaction system was supplemented to 2000 mL with phosphate buffer at pH = 7.5, and the reaction was carried out at a temperature of 55 ° C and 150 rpm for 15 hours. The reaction solution was detected by liquid phase detection using the method of Example 4 ( Figure 6 ), the residual concentration of the substrate was 63 mM, the conversion rate was 68.5%, the L-PPT was 136 mM, and the ee value of the product L-phosphinothricin was 99.9%.

[0093] Example 9: Conversion of 200 mM 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid by E. coli BL21(DE3) / pETDuet-LcGluDH-M91G-ADH

[0094] In a 3L conventional stirred reactor, 200mL of 2M 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid solution prepared by the method of Example 2 was added, the pH was adjusted to 7.5 with aqueous ammonia, and a final concentration of 240mM isopropanol and 0.4mM NAD + , 10 g / L of E. coli BL21 (DE3) / pETDuet-LcGluDH-M91G-ADH prepared by the method of Example 3, the reaction system was supplemented to 2000 mL with phosphate buffer at pH = 7.5, and the reaction was carried out at a temperature of 55 ° C and 150 rpm for 15 hours. The reaction solution was detected by liquid phase detection using the method of Example 4 ( Figure 6 ), the residual concentration of substrate was 40 mM, the substrate conversion rate was 80%, L-PPT was 159 mM, and the ee value of the product L-glufosinate was 99.9%.

[0095] Example 10: Conversion of 200 mM 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid by E. coli BL21(DE3) / pETDuet-LcGluDH-V73C-M91G-ADH

[0096] In a 1L reactor, 200 mL of 2M substrate 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid solution prepared by the method of Example 2 was added, the pH was adjusted to 7.5 with ammonia water, and a final concentration of 240 mM isopropanol and 0.4 mM NAD +, 10 g / L of E. coli BL21 (DE3) / pETDuet-LcGluDH-ADH prepared by the method of Example 3, the reaction system was supplemented to 2000 mL with phosphate buffer at pH = 7.5, and the reaction was carried out at a temperature of 55 ° C and 150 rpm for 15 hours. The reaction solution was detected by liquid phase detection using the method of Example 4 ( Figure 6 ), the residual concentration of substrate was 0 mM, the substrate conversion rate was 100%, L-PPT was 199 mM, and the ee value of the product L-glufosinate was 99.9%.

[0097] Example 11: Conversion of 800 mM 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid by E. coli BL21(DE3) / pETDuet-LcGluDH-ADH

[0098] In a 3L conventional stirred reactor, 800mL of 2M 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid solution prepared by the method of Example 2 was added, the pH was adjusted to 7.5 with aqueous ammonia, and then 960mM isopropanol and 0.8mM NAD were added. + , 40 g / L of E. coli BL21 (DE3) / pETDuet-LcGluDH-ADH prepared by the method of Example 3, the reaction system was supplemented to 2000 mL with phosphate buffer at pH = 7.5, and the reaction was carried out at a temperature of 55 ° C and 150 rpm for 15 hours. The reaction solution was detected by liquid phase detection using the method of Example 4 ( Figure 7 ), the residual concentration of substrate was 560 mM, the substrate conversion rate was 30%, L-PPT was 239 mM, and the ee value of the product L-glufosinate was 99.9%.

[0099] Example 12: Conversion of 800 mM 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid by E. coli BL21(DE3) / pETDuet-LcGluDH-V73C-ADH

[0100] In a 3L conventional stirred reactor, 800mL of 2M 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid solution prepared by the method of Example 2 was added, the pH was adjusted to 7.5 with aqueous ammonia, and isopropanol at a final concentration of 960mM and NAD at a final concentration of 0.8mM were added. + , 40 g / L of E. coli BL21 (DE3) / pETDuet-LcGluDH-V73C-ADH prepared by the method of Example 3, the reaction system was supplemented to 2000 mL with phosphate buffer at pH = 7.5, and the reaction was carried out at a temperature of 55 ° C and 150 rpm for 15 hours. The reaction solution was detected by liquid phase detection using the method of Example 4 ( Figure 7), the residual concentration of substrate was 240 mM, the substrate conversion rate was 70%, L-PPT was 559 mM, and the ee value of the product L-phosphinothricin was 99.9%.

[0101] Example 13: Conversion of 800 mM 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid by E. coli BL21(DE3) / pETDuet-LcGluDH-M91G-ADH

[0102] In a 3L conventional stirred reactor, 800mL of 2M 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid solution prepared by the method of Example 2 was added, the pH was adjusted to 7.5 with aqueous ammonia, and isopropanol at a final concentration of 960mM and NAD at a final concentration of 0.8mM were added. + , 40 g / L of E. coli BL21 (DE3) / pETDuet-LcGluDH-M91G-ADH prepared by the method of Example 3, the reaction system was supplemented to 2000 mL with phosphate buffer at pH = 7.5, and the reaction was carried out at a temperature of 55 ° C and 150 rpm for 15 hours. The reaction solution was detected by liquid phase detection using the method of Example 4 ( Figure 7 ), the residual substrate concentration was 120 mM, the substrate conversion rate was 85%, L-PPT was 680 mM, and the ee value of the product L-glufosinate was 99.9%.

[0103] Example 14: Conversion of 800 mM 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid by E. coli BL21(DE3) / pETDuet-LcGluDH-V73C-M91G-ADH

[0104] In a 3L conventional stirred reactor, 800mL of 2M 2-carbonyl-4-(hydroxymethylphosphonyl)-butyric acid solution prepared by the method of Example 2 was added, the pH was adjusted to 7.5 with aqueous ammonia, and isopropanol at a final concentration of 960mM and NAD at a final concentration of 0.8mM were added. + , 40 g / L of E. coli BL21 (DE3) / pETDuet-LcGluDH-V73C-M91G-ADH prepared by the method of Example 3, the reaction system was supplemented to 2000 mL with phosphate buffer at pH = 7.5, and the reaction was carried out at a temperature of 55 ° C and 150 rpm for 15 hours. The reaction solution was detected by liquid phase detection using the method of Example 4 ( Figure 7 ), the residual substrate concentration was 0 mM, the substrate conversion rate was 99.9%, the L-PPT was 799 mM, and the ee value of the product L-phosphinothricin was 99.9%.

Claims

1. A method for synthesizing L-phosphinothricin ammonium, characterized in that: The method comprises the following steps: The wet cells obtained by fermentation culture of recombinant Escherichia coli engineering bacteria co-expressing the coding genes of glufosinate ammonium dehydrogenase and alcohol dehydrogenase or the wet cells obtained by fermentation culture of recombinant Escherichia coli engineering bacteria co-expressing the coding genes of glufosinate ammonium dehydrogenase mutant and alcohol dehydrogenase were used as catalysts, 2-carbonyl-4-(hydroxymethylphosphonyl)butyric acid was used as substrate, isopropanol, NAD + , a reaction system is formed with a buffer solution of pH 6-8 as a reaction medium, a conversion reaction is carried out at 40-60° C. and 100-200 rpm, and the reaction solution is separated and purified to obtain L-phosphinothricin ammonium; the glufosinate ammonium dehydrogenase mutant is obtained by performing a single mutation or a double mutation at the 73rd or 91st position of the glufosinate ammonium dehydrogenase with an amino acid sequence as shown in SEQ ID NO.

2.

2. The method for synthesizing L-phosphinothricin as claimed in claim 1, characterized in that: The 2-carbonyl-4-(hydroxymethylphosphonyl)butyric acid is prepared according to the following steps: (1) using diethyl methylphosphite and acrylic acid as raw materials, and subjecting them to an addition reaction at a temperature of 100-150° C. and a pressure of 0.5-5 MPa to synthesize ethyl 3-(methylethoxyphosphonyl)propionate; (2) After condensation reaction of ethyl 3-(methylethoxyphosphonyl)propionate with sodium ethoxide and diethyl oxalate at a temperature of 40-80° C. and a pressure of 1-5 MPa, the pH is adjusted to 6-8, and a hydrolysis reaction is carried out at 50-70° C. The reaction solution is distilled to recover the by-product ethanol, and then filtered to remove sodium chloride, and the filtrate is taken to obtain 2-carbonyl-4-(hydroxymethylphosphonyl)butyric acid.

3. The method for synthesizing L-phosphinothricin as claimed in claim 2, characterized in that: In step (1), the volume ratio of acrylic acid to diethyl methyl phosphite is 1-5:

1.

4. The method for synthesizing L-phosphinothricin as claimed in claim 2, characterized in that: The condensation reaction conditions in step (2) are: reaction at a temperature of 60° C. and a pressure of 1.5 MPa for 8 hours; and the hydrolysis reaction temperature is 60° C.

5. The method for synthesizing L-phosphinothricin as claimed in claim 2, characterized in that: In step (2), the volume amount of ethyl 3-(methylethoxyphosphonyl)propionate is 20-50 L / kg based on the mass of sodium ethoxide; the mass ratio of sodium ethoxide to diethyl oxalate is 1:1-3.

6. The method for synthesizing L-phosphinothricin as claimed in claim 1, characterized in that: In the reaction system, the final concentration of wet bacteria is 10-40g / L, the final concentration of substrate is 200-800mM, the final concentration of isopropanol is 200-1000mM, and the final concentration of NAD + The final concentration added is 0.4-0.8 mM.

7. The method for synthesizing L-phosphinothricin as claimed in claim 1, characterized in that: The glufosinate dehydrogenase mutant is a mutant in which the amino acid sequence shown in SEQ ID NO.2 is mutated to one of the following: (1) the valine at position 73 is mutated to cysteine; (2) the methionine at position 91 is mutated to glycine; (3) the valine at position 73 is mutated to cysteine ​​and the methionine at position 91 is mutated to glycine.

8. The method for synthesizing L-phosphinothricin as claimed in claim 1, characterized in that: The catalyst preparation method comprises the following steps: inoculating a recombinant Escherichia coli engineering bacterium containing a co-expression gene encoding a glufosinate dehydrogenase and an alcohol dehydrogenase or a recombinant Escherichia coli engineering bacterium containing a gene encoding a glufosinate dehydrogenase mutant and an alcohol dehydrogenase into an LB liquid culture medium containing ampicillin at a final concentration of 50 μg / mL, culturing at 37°C for 8 hours, inoculating the culture medium into a fresh LB liquid culture medium containing ampicillin at a final concentration of 50 μg / mL at a volume concentration of 2%, culturing at 37°C and 180 rpm for 2 hours, adding IPTG at a final concentration of 0.1 mM to the culture solution, culturing at 18°C ​​for 14 hours, and centrifuging at 4°C and 8000 rpm for 10 minutes to obtain corresponding wet bacterial cells; the amino acid sequence of the alcohol dehydrogenase is shown in SEQ ID NO.

4.

9. A glufosinate dehydrogenase mutant for use in the method of claim 1 for synthesizing L-glufosinate, characterized in that: The glufosinate ammonium dehydrogenase mutant is obtained by performing a single mutation or a double mutation at the 73rd or 91st position of the glufosinate ammonium dehydrogenase with an amino acid sequence as shown in SEQ ID NO.

2.

10. The mutant according to claim 9, characterized in that The mutant is a mutant in which the amino acid sequence shown in SEQ ID NO.2 is mutated into one of the following: (1) the valine at position 73 is mutated into cysteine; (2) the methionine at position 91 is mutated into glycine; (3) the valine at position 73 is mutated into cysteine ​​and the methionine at position 91 is mutated into glycine.

Citation Information

Cited By

  • Electrochemical-biological oxidoreductase cascade catalysis method

    CN121852934A